Abstract:As a natural flavonoid, apigenin (APG) has garnered considerable attention for its broad pharmacological properties. Unfortunately, the extremely poor aqueous solubility greatly restricts its clinical efficacy. Cocrystallization has been taken as an important approach to modulate physicochemical properties of parent drug. In this paper, piperazine (PIP) has been selected to assembly with APG and APG–PIP cocrystal has been successfully fabricated and characterized by single crystal X-ray diffraction and various analytical methods. Single-crystal X-ray diffraction analysis indicates APG–PIP crystallizes in the P 2 1 / c space group of monoclinic system and comprises neutral APG and PIP with the ratio of 1:1. APG and PIP are linked via O–H ⋅ ⋅ ⋅ N/N–H ⋅ ⋅ ⋅ O hydrogen bonds with a resulting 2D fes network. The 2D networks are further extended via π ⋅ ⋅ ⋅ π stacking interactions to afford its 3D architecture. The APG illustrates highly enhanced solubility and dissolving rate in APG–PIP cocrystal comparing with parent APG. It is notable that APG–PIP presents different equilibrium concentrations of APG along with insoluble residue when different dosages of APG–PIP are introduced. We speculate that APG and PIP may not be released equally within APG–PIP in aqueous medium due to their neutral nature and huge difference in solubility, and the existence of PIP can facilitate the dissolving of APG. This speculation has been further confirmed by investigation of relationship between equilibrium concentrations of APG and dosage of APG–PIP as well as powder dissolution experiment. The equilibrium concentrations are 0.118, 0.382, 0.556, 0.767, and 0.904 mg/mL when 5, 10, 15, 20, and 25 mg APG–PIP was put into 5 mL H 2 O and reveals good linear relation. The "spring and parachute" phenomenon and final similar solubility with parent APG in powder dissolution profile can be ascribed to the synergetic effect of metastable supersaturation and decreased PIP concentration due to withdrawing-replenishing operation.

Imaging supermolecular interactions of the pharmaceutical-cocrystal of apigenin-nicotinamide binding with serum albumin

Preparation of quercetin-nicotinamide cocrystals and their evaluation underin vivoandin vitroconditions

A pharmaceutical cocrystal of apigenin with piperazine: preparation, structural characterization, and dissolution performance

Cocrystals of Isoliquiritigenin with Enhanced Pharmacokinetic Performance

Simultaneously Improving the Physicochemical Properties, Dissolution Performance and Bioavailability of Apigenin and Daidzein by Co-crystallization with Theophylline.

Theoretical Exploration on the Molecular Configurations, Solubilities and Chemical Reactivities of Four Flavonoid-Based Co-Crystals

Mechanistic Study on Complexation-Induced Spring and Hover Dissolution Behavior of Ibuprofen-Nicotinamide Cocrystal

Preparation and Characterization of Novel Pharmaceutical Co-Crystals: Ticagrelor with Nicotinamide

Studies on the Synthesis, Structural Characterization, Hirshfeld Analysis and Stability of Apovincamine (api) and Its Co-Crystal (terephthalic Acid: Apovincamine=1:2)

Bioavailability-Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance

Recent Advances in Pharmaceutical Cocrystals: A Focused Review of Flavonoid Cocrystals

Preparation of Apigenin Nanocrystals Using Supercritical Antisolvent Process for Dissolution and Bioavailability Enhancement.

Insight into the Formation of Cocrystals of Flavonoids and 4,4′-Vinylenedipyridine: Heteromolecular Hydrogen Bonds, Molar Ratio, and Structural Analysis

Synthesis, crystal structure, and solubility study of a supramolecular assembly cocrystal formed by levofloxacin and nicotinic acid

Preparation of Inclusion Complex of Apigenin-Hydroxypropyl-β-cyclodextrin by Using Supercritical Antisolvent Process for Dissolution and Bioavailability Enhancement

Using the Cocrystal Approach as a Promising Drug Delivery System to Enhance the Dissolution and Bioavailability of Formononetin Using an Imidazole Coformer

Synthesis, characterization, in silico and in vitro assessment of 2-aminopyridine nicotinamide cocrystal as a new agent for breast cancer therapy

Azilsartan-nicotinamide cocrystal: Preparation, characterization and in vitro / vivo evaluation

Cocrystal of Sulfamethazine and P-Aminobenzoic Acid: Structural Establishment and Enhanced Antibacterial Properties

Cocrystal and Its Application in the Field of Active Pharmaceutical Ingredients and Food Ingredients.

X‐Ray Crystallography and Antimicrobial Activity of Synthetic Cyanoguanidinophenytoin Cocrystals